TP53 and hepatocellular carcinoma: Hence, directing attention toward the interplay between GOF mutant p53 proteins and TAp63 and TAp73 appears viable for prospective HCC treatment (Oren and Rotter, 2010[117]; Soussi and Wiman, 2015[141]).